Skip to main content
Journal cover image

Interstitial nephritis in melanoma patients secondary to PD-1 checkpoint inhibitor

Publication ,  Journal Article
Escandon, J; Peacock, S; Trabolsi, A; Thomas, DB; Layka, A; Lutzky, J
Published in: Journal for ImmunoTherapy of Cancer
December 2017

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Journal for ImmunoTherapy of Cancer

DOI

EISSN

2051-1426

Publication Date

December 2017

Volume

5

Issue

1

Publisher

BMJ

Related Subject Headings

  • 3211 Oncology and carcinogenesis
  • 3204 Immunology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Escandon, J., Peacock, S., Trabolsi, A., Thomas, D. B., Layka, A., & Lutzky, J. (2017). Interstitial nephritis in melanoma patients secondary to PD-1 checkpoint inhibitor. Journal for ImmunoTherapy of Cancer, 5(1). https://doi.org/10.1186/s40425-016-0205-2
Escandon, Julia, Stephanie Peacock, Asaad Trabolsi, David B. Thomas, Ayman Layka, and Jose Lutzky. “Interstitial nephritis in melanoma patients secondary to PD-1 checkpoint inhibitor.” Journal for ImmunoTherapy of Cancer 5, no. 1 (December 2017). https://doi.org/10.1186/s40425-016-0205-2.
Escandon J, Peacock S, Trabolsi A, Thomas DB, Layka A, Lutzky J. Interstitial nephritis in melanoma patients secondary to PD-1 checkpoint inhibitor. Journal for ImmunoTherapy of Cancer. 2017 Dec;5(1).
Escandon, Julia, et al. “Interstitial nephritis in melanoma patients secondary to PD-1 checkpoint inhibitor.” Journal for ImmunoTherapy of Cancer, vol. 5, no. 1, BMJ, Dec. 2017. Crossref, doi:10.1186/s40425-016-0205-2.
Escandon J, Peacock S, Trabolsi A, Thomas DB, Layka A, Lutzky J. Interstitial nephritis in melanoma patients secondary to PD-1 checkpoint inhibitor. Journal for ImmunoTherapy of Cancer. BMJ; 2017 Dec;5(1).
Journal cover image

Published In

Journal for ImmunoTherapy of Cancer

DOI

EISSN

2051-1426

Publication Date

December 2017

Volume

5

Issue

1

Publisher

BMJ

Related Subject Headings

  • 3211 Oncology and carcinogenesis
  • 3204 Immunology